Form 4: Recursion CFO's Routine Stock Withholding for Taxes

Recursion Pharmaceuticals' CFO, Ben R Taylor, reported a routine disposition of 11,908 Class A Common Stock shares to cover tax obligations related to restricted stock units.

Summary

• Ben R Taylor, Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX), reported a transaction on August 15, 2025.
• The transaction involved the disposition of 11,908 shares of Class A Common Stock at a price of $5.64 per share.
• These shares were withheld by the Issuer to satisfy tax withholding and remittance obligations associated with the net settlement of restricted stock units.
• Following this transaction, Ben R Taylor beneficially owns 811,226 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction for tax withholding purposes, which is neutral in sentiment. It does not indicate any positive or negative discretionary action by the insider or the company.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

This filing is a routine insider transaction for tax purposes and does not reflect broader industry trends or competitive positioning. It is a standard compliance disclosure for executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in insider sentiment or company fundamentals.

Key Dates

Keywords

Recursion Pharmaceuticals, RXRX, SEC Form 4, Insider Transaction, Stock Withholding, Restricted Stock Units, CFO, Ben R Taylor